Literature DB >> 33090806

Covalent Organic Framework Embedded with Magnetic Nanoparticles for MRI and Chemo-Thermotherapy.

Farah Benyettou1, Gobinda Das1, Anjana Ramdas Nair1, Thirumurugan Prakasam1, Digambar B Shinde2, Sudhir Kumar Sharma1, Jamie Whelan1, Yoann Lalatonne3,4, Hassan Traboulsi5, Renu Pasricha1, Osama Abdullah1, Ramesh Jagannathan1, Zhiping Lai2, Laurence Motte6, Felipe Gándara7, Kirsten C Sadler1, Ali Trabolsi1.   

Abstract

Nanoscale imine-linked covalent organic frameworks (nCOFs) were first loaded with the anticancer drug Doxorubicin (Dox), coated with magnetic iron oxide nanoparticles (γ-Fe2O3 NPs), and stabilized with a shell of poly(l-lysine) cationic polymer (PLL) for simultaneous synergistic thermo-chemotherapy treatment and MRI imaging. The pH responsivity of the resulting nanoagents (γ-SD/PLL) allowed the release of the drug selectively within the acidic microenvironment of late endosomes and lysosomes of cancer cells (pH 5.4) and not in physiological conditions (pH 7.4). γ-SD/PLL could efficiently generate high heat (48 °C) upon exposure to an alternating magnetic field due to the nCOF porous structure that facilitates the heat conduction, making γ-SD/PLL excellent heat mediators in an aqueous solution. The drug-loaded magnetic nCOF composites were cytotoxic due to the synergistic toxicity of Dox and the effects of hyperthermia in vitro on glioblastoma U251-MG cells and in vivo on zebrafish embryos, but they were not significantly toxic to noncancerous cells (HEK293). To the best of our knowledge, this is the first report of multimodal MRI probe and chemo-thermotherapeutic magnetic nCOF composites.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33090806     DOI: 10.1021/jacs.0c05381

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  In vivo oral insulin delivery via covalent organic frameworks.

Authors:  Farah Benyettou; Nawel Kaddour; Thirumurugan Prakasam; Gobinda Das; Sudhir Kumar Sharma; Sneha Ann Thomas; Fadia Bekhti-Sari; Jamie Whelan; Mohammed A Alkhalifah; Mostafa Khair; Hassan Traboulsi; Renu Pasricha; Ramesh Jagannathan; Nassima Mokhtari-Soulimane; Felipe Gándara; Ali Trabolsi
Journal:  Chem Sci       Date:  2021-04-06       Impact factor: 9.825

2.  Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy.

Authors:  Mingming Song; Wentao Xia; Zixuan Tao; Bin Zhu; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 3.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14

4.  Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy.

Authors:  Liang Chen; Wenxing Wang; Jia Tian; Fanxing Bu; Tiancong Zhao; Minchao Liu; Runfeng Lin; Fan Zhang; Myongsoo Lee; Dongyuan Zhao; Xiaomin Li
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

Review 5.  Smart magnetic resonance imaging-based theranostics for cancer.

Authors:  Beatriz Brito; Thomas W Price; Juan Gallo; Manuel Bañobre-López; Graeme J Stasiuk
Journal:  Theranostics       Date:  2021-08-07       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.